Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Kura Oncology (KURA) Shares Outstanding (Weighted Average): 2024-2025

Historic Shares Outstanding (Weighted Average) for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $86.8 million.

  • Kura Oncology's Shares Outstanding (Weighted Average) rose 13.26% to $86.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $86.8 million, marking a year-over-year increase of 13.26%. This contributed to the annual value of $77.8 million for FY2024, which is 4.70% up from last year.
  • Latest data reveals that Kura Oncology reported Shares Outstanding (Weighted Average) of $86.8 million as of Q3 2025, which was up 0.26% from $86.6 million recorded in Q2 2025.
  • Kura Oncology's Shares Outstanding (Weighted Average)'s 5-year high stood at $86.8 million during Q3 2025, with a 5-year trough of $76.1 million in Q1 2024.